Tower Research Capital (TRC)’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58K Sell
82
-34,583
-100% -$1.09M ﹤0.01% 4454
2025
Q4
$1.02M Sell
34,665
-152,822
-82% -$4.25M 0.02% 507
2025
Q3
$4.73M Sell
187,487
-106,186
-36% -$2.59M 0.13% 132
2025
Q2
$7.05M Buy
293,673
+293,358
+93,130% +$6.8M 0.19% 90
2025
Q1
$7.21K Sell
315
-4,254
-93% -$103K ﹤0.01% 3972
2024
Q4
$116K Sell
4,569
-12,892
-74% -$327K ﹤0.01% 2074
2024
Q3
$435K Buy
17,461
+11,810
+209% +$350K 0.01% 957
2024
Q2
$168K Sell
5,651
-6,900
-55% -$191K ﹤0.01% 2210
2024
Q1
$378K Buy
12,551
+3,481
+38% +$96.6K 0.01% 1028
2023
Q4
$259K Buy
9,070
+8,790
+3,139% +$258K ﹤0.01% 1891
2023
Q3
$10.4K Sell
280
-2,987
-91% -$114K ﹤0.01% 4116
2023
Q2
$127K Buy
3,267
+2,663
+441% +$104K ﹤0.01% 1887
2023
Q1
$22K Sell
604
-3,172
-84% -$100K ﹤0.01% 3347
2022
Q4
$116K Buy
+3,776
New +$117K ﹤0.01% 1721

Other funds holding RTO

Tower Research Capital (TRC)'s RTO Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Rentokil (RTO) stake by 100% in Q1 2026, selling an estimated $1.09M and leaving 82 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #4454.

Tower Research Capital (TRC) first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.05M in Q2 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Tower Research Capital (TRC) held 82 shares of Rentokil worth $2.58K as of Q1 2026.
  • Tower Research Capital (TRC) sold 34,583 Rentokil shares in Q1 2026, an estimated $1.09M.
  • Rentokil made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4454 holding.
  • Tower Research Capital (TRC) first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s Rentokil position peaked at $7.05M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.